IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis

ABSTRACT Inflammation and myocardial weakness, two major hallmarks of chronic viral myocarditis (VMC), often lead to dilated cardiomyopathy or chronic heart failure. It has been reported that indoleamine 2,3-dioxygenase-1 (IDO1) may play a pathogenic role in the progression of inflammatory diseases. Hence, the study is set out to investigate the potential role of IDO1 in chronic VMC by establishing a mouse model of VMC by intraperitoneally injected with coxsackievirus B3 (CVB3). After model establishment, the expression of IDO1 was determined by RT-qPCR and Western blot analysis. IDO1 was identified as an up-regulated gene in CVB3-induced VMC. Then, in order to elucidate the potential role of IDO1 in VMC, macrophages were isolated and treated with the overexpression plasmid of IDO1 or IDO1 inhibitor (1-MT). After that, these transfected macrophages were co-cultured with normal cardiomyocytes, followed by measurement of inflammatory factors and evaluation of cardiomyocyte injury. The overexpression of IDO1 was observed to significantly enhance the levels of interleukin (IL)-6, IL-1β and tumor necrosis factor-α (TNF-α), as well as lactate dehydrogenase (LDH) activity and malondialdehyde (MDA) content. By contrast, the treatment of 1-MT in macrophages reversed the promoting effects of IDO1 on cardiomyocyte injury. Co-culture experiment showed that overexpressed IDO1 impaired cardiomyocyte, which was alleviated upon treatment of 1-MT. Taken together, the key findings of the present study provide evidence that 1-MT-mediated IDO1 suppression could potentially reduce inflammatory response in macrophages and consequently ameliorate cardiomyocyte injury in mice with VMC.

[1]  Lijun Sun,et al.  A patent review of IDO1 inhibitors for cancer , 2018, Expert opinion on therapeutic patents.

[2]  Fangxuan Li,et al.  IDO1: An important immunotherapy target in cancer treatment , 2017, International immunopharmacology.

[3]  J. Mei,et al.  Immunosuppressive macrophages induced by IDO1 promote the growth of endometrial stromal cells in endometriosis. , 2017, Molecular medicine reports.

[4]  P. Jakob,et al.  In vivo T2* weighted MRI visualizes cardiac lesions in murine models of acute and chronic viral myocarditis , 2017, PloS one.

[5]  Li Yue-chun,et al.  Right Cervical Vagotomy Aggravates Viral Myocarditis in Mice Via the Cholinergic Anti-inflammatory Pathway , 2017, Front. Pharmacol..

[6]  Li Yue-chun,et al.  The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy , 2016, Front. Pharmacol..

[7]  Yingying Zhang,et al.  Silencing MicroRNA-155 Attenuates Cardiac Injury and Dysfunction in Viral Myocarditis via Promotion of M2 Phenotype Polarization of Macrophages , 2016, Scientific Reports.

[8]  S. Huber.  Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis. , 2016, Current pharmaceutical design.

[9]  V. Fuster,et al.  Viral myocarditis—diagnosis, treatment options, and current controversies , 2015, Nature Reviews Cardiology.

[10]  M. Salvadori,et al.  Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer , 2015, Medical Oncology.

[11]  G. Prendergast,et al.  IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. , 2014, International immunology.

[12]  H. Tomita,et al.  Indoleamine 2,3-dioxygenase 1 is upregulated in activated microglia in mice cerebellum during acute viral encephalitis , 2014, Neuroscience Letters.

[13]  Wan-Li Liu,et al.  Epstein-Barr Virus Infection Induces Indoleamine 2,3-Dioxygenase Expression in Human Monocyte-Derived Macrophages through p38/Mitogen-Activated Protein Kinase and NF-κB Pathways: Impairment in T Cell Functions , 2014, Journal of Virology.

[14]  Xin Wang,et al.  Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration , 2014, Leukemia & lymphoma.

[15]  S. Rutella,et al.  Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia , 2013, Oncotarget.

[16]  H. Tomita,et al.  IDO1 Plays an Immunosuppressive Role in 2,4,6-Trinitrobenzene Sulfate–Induced Colitis in Mice , 2013, The Journal of Immunology.

[17]  R. Newberry,et al.  IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. , 2013, Gastroenterology.

[18]  J. Zhong,et al.  Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. , 2013, Life sciences.

[19]  D. Fuchs,et al.  IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis , 2013, PLoS pathogens.

[20]  E. Jeon,et al.  Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans , 2013, Microbiology and immunology.

[21]  N. Bowles,et al.  Cardiac-Specific Overexpression of Melanoma Differentiation–Associated Gene-5 Protects Mice From Lethal Viral Myocarditis , 2013, Circulation. Heart failure.

[22]  M. Matsuzaki,et al.  Diverse stage-dependent effects of glucocorticoids in a murine model of viral myocarditis. , 2013, Journal of cardiology.

[23]  J. Mei,et al.  Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway. , 2013, International journal of clinical and experimental pathology.

[24]  S. Rutella,et al.  Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma , 2012, Journal of Translational Medicine.

[25]  K. Klingel,et al.  The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression , 2012, Basic Research in Cardiology.

[26]  T. Eleftheriadis,et al.  The Indoleamine 2,3-dioxygenase Inhibitor 1-methyl-tryptophan Suppresses Mitochondrial Function, Induces Aerobic Glycolysis and Decreases Interleukin-10 Production in Human Lymphocytes , 2012, Immunological investigations.

[27]  S. Heymans,et al.  Interactions between the extracellular matrix and inflammation during viral myocarditis. , 2012, Immunobiology.

[28]  A. Hara,et al.  l-Tryptophan–Kynurenine Pathway Metabolites Regulate Type I IFNs of Acute Viral Myocarditis in Mice , 2012, The Journal of Immunology.

[29]  Ping Wu,et al.  Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[30]  A. Cesario,et al.  The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer. , 2011, Current medicinal chemistry.

[31]  Kazuo Suzuki,et al.  Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO) , 2011, PloS one.

[32]  Qian Wang,et al.  Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. , 2010, Blood.

[33]  Jiong Cai,et al.  Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells , 2010, Molecular and Cellular Biochemistry.

[34]  D. Čiháková,et al.  Alternatively activated macrophages in infection and autoimmunity. , 2009, Journal of autoimmunity.

[35]  Liu Huanqi,et al.  Effects of clenbuterol on leaves of LDH and antioxidant capacity of myocardium in mice. , 2009 .

[36]  W. Abelmann,et al.  Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. , 2005, American journal of physiology. Heart and circulatory physiology.

[37]  N. Rose,et al.  Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .

[38]  H. Link,et al.  Interferon‐γ‐modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis , 2004 .

[39]  W. Xiao.  Influence of Yi Xin Drink to SOD and MDA activity in mice with viral myocarditis , 2004 .

[40]  N. Rose,et al.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.

[41]  J. Atkinson,et al.  Pertussis toxin‐sensitive Gi‐proteins and intracellular calcium sensitivity of vasoconstriction in the intact rat tail artery , 2000, British journal of pharmacology.